About this compound
Tirzepatide is a synthetic dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is supplied as a lyophilized powder in a sealed vial, sterile-filtered and sealed under inert gas.
Each lot is assayed by reverse-phase HPLC and confirmed by mass spectrometry before release. Lot documentation ships with the order and is archived to your account.
Handling and storage
- Store lyophilized powder at −20 °C, protected from light.
- Once reconstituted, refrigerate at 2–8 °C and use within the working window for your protocol.
- Avoid repeated freeze-thaw cycles; aliquot before freezing.
- Handle under aseptic conditions with appropriate personal protective equipment.
Research use only. Not for human or animal consumption. We do not provide or suggest dosing, mixing, or titration instructions.
Reviews
There are no reviews yet.